Figure 3.

A‐F, Joinpoint analyses of six‐monthly prescribing trends for codeine for treatment of pain in children 0‐11 y in (A) France^a, (B‐D) Germany^a, (E) Spain, and (F) the United Kingdom. (A) IMS® France (top left corner). (B) IMS® Germany GP (middle top). (C) IMS® Germany PAED (top right corner). (D) IMS® Germany ENT (bottom left corner). (E) BIFAP (middle bottom). (F) CPRD (bottom right corner). ENT = ear, nose, and throat practice, G = general practice, IMS® = IMS® Disease Analyzer, PAED = paediatric practice, Proportion = proportion of children with a codeine prescription. The dots represent the six‐monthly prevalences. The lines represent the selected joinpoint model. ^aOwn calculations, based on IMS® Disease Analyzer (France, Germany) [Colour figure can be viewed at wileyonlinelibrary.com]